Skip to main content
PTSD & Trauma

Deep TMS with Brief Exposure for PTSD: Multisite Trial

Grade DRandomized, sham-controlled trial2021

What did this study find?

In this multisite trial, 125 outpatients with PTSD received deep TMS or sham immediately after brief exposure to their trauma narrative. Both groups improved significantly, but improvement was smaller in the deep TMS group than in the sham group at five and nine weeks. The authors attributed the improvement to the brief exposure procedure.

What are the details of this record?

Full citation
Isserles M, Tendler A, Roth Y, et al. Deep Transcranial Magnetic Stimulation Combined With Brief Exposure for Posttraumatic Stress Disorder: A Prospective Multisite Randomized Trial. Biol Psychiatry. 2021;90(10):721-728. doi:10.1016/j.biopsych.2021.04.019.
Journal
Biological Psychiatry
Authors
Isserles M, Tendler A, Roth Y, Bystritsky A, Blumberger DM, Ward H, Feifel D, Viner L, Duffy W, Zohar J, Keller CJ, Bhati MT, Etkin A, George MS, Filipcic I, Lapidus K, Casuto L, Vaishnavi S, Stein A, Deutsch L, Deutsch F, Morales O, Daskalakis ZJ, Zangen A, Ressler KJ
Study design
Randomized, sham-controlled trial
Sample size and population
125 outpatients with PTSD
Evidence grade
Grade D on the BioReg grading scale
Reported findings
Both groups improved significantly, but CAPS-5 improvement was smaller with deep TMS than with sham at 5 weeks (16.32 vs 20.52) and at 9 weeks (19.0 vs 24.4). The authors suggest brief script-driven exposure alone may account for the improvement.

A positive PEMF study is not evidence for a specific device unless the signal parameters studied, frequency, intensity, waveform, and exposure duration, are reasonably comparable to what that device produces. Where this record does not list those parameters, the source report did not publish them. See the grading methodology. Library last reviewed 2026-08-27.